BiotechTube

G-CSF + Early retreatment with ATG

Phase 3Terminated
0 watching 0 views this week๐Ÿ“ˆ Rising
76
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Aplastic Anaemia

Conditions

Aplastic Anaemia

Trial Timeline

Mar 1, 2001 โ†’ Nov 1, 2010

NCT ID
NCT01163942

About G-CSF + Early retreatment with ATG

G-CSF + Early retreatment with ATG is a phase 3 stage product being developed by Sanofi for Aplastic Anaemia. The current trial status is terminated. This product is registered under clinical trial identifier NCT01163942. Target conditions include Aplastic Anaemia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01163942Phase 3Terminated

Competing Products

20 competing products in Aplastic Anaemia

See all competitors
ProductCompanyStageHype Score
CS-7017 + PaclitaxelDaiichi SankyoPhase 1/2
41
efatutazone + paclitaxelDaiichi SankyoPhase 2
52
AlefaceptAstellas PharmaPhase 1
33
RomiplostimKyowa KirinPhase 2/3
65
Lenvatinib 24 mgEisaiPhase 2
52
RomiplostimKyowa KirinPhase 2/3
65
RomiplostimKyowa KirinPhase 2/3
65
AMG531Kyowa KirinPhase 2
52
Lenvatinib + NivolumabOno PharmaceuticalPhase 2
52
Hetrombopag Olamine TabletJiangsu Hengrui MedicinePhase 1
33
Hetrombopag Olamine + PlaceboJiangsu Hengrui MedicinePhase 3
77
Trappa ethanolamine tablets ; ciclosporin + Placebo ; ciclosporinJiangsu Hengrui MedicinePhase 2
52
Hetrombopag Olamine Tablet๏ผ›Ciclosporin Soft CapsuleJiangsu Hengrui MedicinePhase 1
33
Hetrombopag Olamine TabletJiangsu Hengrui MedicinePhase 1
33
Hetrombopag OlamineJiangsu Hengrui MedicinePhase 1/2
41
Hetrombopag Olamine+Standard Therapy + Placebo+Standard TherapyJiangsu Hengrui MedicinePhase 3
77
durvalumab + tremelimumabAstraZenecaPhase 1
33
PembrolizumabMerckPhase 2
52
PosaconazoleMerckPhase 2
52
Cohort 1: hATG, CsA, EPAG Day 14 to Month 6 + Cohort 2: hATG, CsA, EPAG Day 14 to Month 3 + Cohort 3: hATG, CsA (dose reduced), EPAG day 1 to month 6 + Extension CohortNovartisPhase 1/2
41

Other Products from Sanofi

AdacelยฎApproved
84
LACTIC ACID(ND)Approved
84
DupilumabApproved
84
glatiramer acetateApproved
84
INSULIN GLULISINE + INSULIN GLARGINEApproved
84